Ultrasound-based radiomics model for predicting molecular biomarkers in breast cancer
Frontiers in Oncology · 31.07.2023 · 13
DOI: 10.3389/fonc.2023.1216446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 31.07.2023. Verfasst von Rong Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Breast cancer (BC) is the most common cancer in women and is highly heterogeneous. BC can be classified into four molecular subtypes based on the status of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and proliferation marker protein Ki-67. However, they can only be obtained by biopsy or surgery, which is invasive. Radiomics can noninvasively predict molecular expression via extracting the image features. Nevertheless, there is a scarcity of data available regarding the prediction of molecular biomarker expression using ultrasound (US) images in BC.
Objectives
To investigate the prediction performance of US radiomics for the assessment of molecular profiling in BC.
Methods
A total of 342 patients with BC who underwent preoperative US examination between January 2013 and December 2021 were retrospectively included. They were confirmed by pathology and molecular subtype analysis of ER, PR, HER2 and Ki-67. The radiomics features were extracted and four molecular models were constructed through support vector machine (SVM). Pearson correlation coefficient heatmaps are employed to analyze the relationship between selected features and their predictive power on molecular expression. The receiver operating characteristic curve was used for the prediction performance of US radiomics in the assessment of molecular profiling.
Results
359 lesions with 129 ER- and 230 ER+, 163 PR- and 196 PR+, 265 HER2- and 94 HER2+, 114 Ki-67- and 245 Ki-67+ expression were included. 1314 features were extracted from each ultrasound image. And there was a significant difference of some specific radiomics features between the molecule positive and negative groups. Multiple features demonstrated significant association with molecular biomarkers. The area under curves (AUCs) were 0.917, 0.835, 0.771, and 0.896 in the training set, while 0.868, 0.811, 0.722, and 0.706 in the validation set to predict ER, PR, HER2, and Ki-67 expression respectively.
Conclusion
Ultrasound-based radiomics provides a promising method for predicting molecular biomarker expression of ER, PR, HER2, and Ki-67 in BC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
- Department of Breast, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
- Department of Pathology, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Zitieren
APA
Xu, R., You, T., Liu, C., Lin, Q., Guo, Q., Zhong, G., Liu, L., & Ouyang, Q. (2023). Ultrasound-based radiomics model for predicting molecular biomarkers in breast cancer. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1216446
Vancouver
Xu R, You T, Liu C, Lin Q, Guo Q, Zhong G, et al. Ultrasound-based radiomics model for predicting molecular biomarkers in breast cancer. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1216446
BibTeX
@article{Xu2023,
author = {Xu, Rong and You, Tao and Liu, Chen and Lin, Qing and Guo, Quehui and Zhong, Guodong and Liu, Leilei and Ouyang, Qiufang},
title = {Ultrasound-based radiomics model for predicting molecular biomarkers in breast cancer},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1216446}
}
EUVIMED